You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Italy

Apr 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Italy with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Italy, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Italy for free:

The Consumer Health in Italy market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Italy?
  • What are the major brands in Italy?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Following a positive path

Despite the economic downturn, growth was maintained in consumer health sales in 2010, with particularly strong performances by vitamins and dietary supplements, herbal/traditional remedies and sports nutrition. The positive effect of these more dynamic categories has counteracted the negative effects of maturity in categories such as analgesics, which is also still suffering from the reverse switch of Nimesulide from OTC back to an Rx medicine.

Healthy lifestyles and wellness trends

Owing to consumers’ increasing concern over health and wellbeing, especially amongst middle-age and elderly people, demand for consumer health products continued to grow in 2010. Health consciousness among Italians continues to increase, and there is a growing interest in staying healthy and preventing future illnesses. This has had a positive influence on sales of consumer health products, as consumers are increasingly demanding more natural remedies, as well as products like sports nutrition and vitamins, which are perceived to be a useful aid for staying fit and preventing illnesses. The ageing of the Italian population is strengthening this trend. The main users of such products are people in their 40s, 50s and 60s. As adult people wish to live longer and age gracefully, demand for products like vitamins and dietary supplements, and hair loss treatments is increasing.

Market still fragmented

The competitive environment remained rather fragmented in 2010, with a large number of companies operating in consumer health in Italy. Multinational companies continue to dominate in the consumer health environment, with Bayer remaining in the top spot, followed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA. Whitehall Italia SpA ranked third, due to its strength in vitamins and dietary supplements. The leading players benefit from the growing preference for self-medication, with consumers tending to opt for well-known brands from trusted manufacturers.

Parapharmacies and grocery retailers slowly gaining ground

With the liberalisation of the sale of over-the-counter products through the grocery channel and parapharmacies, the distribution landscape in consumer health is gradually changing in Italy. Chemists/pharmacies remains the leading distribution channel; however, parapharmacies and grocery retailers are increasing their penetration in the Italian market. Nevertheless, in the latter part of the review period, chemists and pharmacies maintained their competitive position in growing markets such as cosmetics and toiletries. Parapharmacies are increasing in numbers, as are pharmacy sections within supermarkets and hypermarkets. In 2010, parapharmacies saw the highest increase in distribution share, as consumers responded positively to the lower prices in these outlets than in chemists, but with a similar level of assistance with regard to OTC products being provided.

Consumer health performance set to improve

Consumer health products are expected to see stronger growth over the forecast period than that seen in the review period. Sales will be driven, once again, by consumers’ interest in health and wellbeing. The increasingly hectic lifestyles and rising stress levels experienced by adults will drive demand for products such as hair loss treatments, as well as for vitamins and dietary supplements. Similarly, consumers’ concern over the negative effects of over-the-counter medicines will boost sales of herbal/traditional remedies. An increasing number of Rx drugs are expected to be switched to over-the-counter status, as the Italian government tries to decrease the cost of the healthcare system. Likewise, the government is expected to intervene in order to support the development of generics. Generally speaking, the OTC market is expected to grow faster in volume than in value, but will still register dynamic growth rates by both measures.

Table of Contents

Table of Contents

Consumer Health in Italy - Industry Overview

EXECUTIVE SUMMARY

Following a positive path

Healthy lifestyles and wellness trends

Market still fragmented

Parapharmacies and grocery retailers slowly gaining ground

Consumer health performance set to improve

KEY TRENDS AND DEVELOPMENTS

Increasing awareness of prevention and healthy lifestyles

Poor economy polarises consumer preferences

Consumers still lack trust in generics and private labels

Distribution dynamics slowly evolving

Increasing interest in herbal remedies

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

Non-prescription Medicines: Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine impacting consumer health

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Italy - Company Profiles

A Menarini Industrie Farmaceutiche Riunite Srl in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2010

Aziende Chimiche Riunite Angelini Francesco ACRAF SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2010

Beiersdorf SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Bayer SpA: Competitive Position 2010

Bracco SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Bracco SpA: Competitive Position 2010

Chiesi Farmaceutici SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2010

Perfetti Van Melle SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Perfetti Van Melle SpA: Competitive Position 2010

Recordati Industria Chimica e Farmaceutica SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2010

Sanofi-Aventis SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 28 Sanofi-Aventis SpA: Competitive Position 2010

Sigma-Tau Industrie Farmaceutiche Riunite SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2010

Zambon Italia SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 34 Zambon Italia SpA: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 35 Zambon Italia SpA: Competitive Position 2010

Adult Mouth Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care recorded growth of 1% in current value in 2010, with sales reaching €88 million. This category includes products for mouth ulcers, oral analgesics and non-prescription mouthwashes. Over the review period, the category was mainly driven by the good performance of mouthwashes. In 2010, mouthwashes continued to perform well, despite the increased competition posed by cosmetic products which fall outside consumer health, such as Listerine and Colgate. The category’s consumer base is mainly made up of elderly people, who use adult mouth care products to alleviate the pain and discomfort related to the use of dental products and dentures. The modest performance in 2010 was due in part to the unstable Italian economic conditions, which led many elderly people on low incomes to opt for Rx products when possible.

SWITCHES

COMPETITIVE LANDSCAPE

  • Societá Italiana Farmaceutici Ravizza SpA (SIFRA) continued to lead adult mouth care in 2010, with a value share of 42% of total category sales, up slightly from the previous year. The company leads the category through its well-established Froben brand. It is followed by GlaxoSmithKline SpA, with a share of 18%, through its Goccemed brand, and Pfizer Consumer Healthcare Srl, with Oraseptic, holding a value share of around 13%.

PROSPECTS

  • Sales of adult mouth care are expected to grow only slowly over the forecast period with a constant value CAGR of less than 1%. Non-prescription mouthwashes will continue to benefit from significant advertising investment to support cosmetic mouthwashes, despite having to compete with such products, as such advertising helps to increase consumer awareness of oral health. Other products, such as those to treat mouth ulcers and oral analgesics, will see only modest advertising support. No other key operators are looking to extend their brands into adult mouth care.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Italy - Category Analysis

HEADLINES

TRENDS

  • The analgesics category continued to benefit in 2010 from the reverse switching of nimesulide to prescription-only status. This followed warnings of possible liver damage caused by nimesulide. Most purchasers of nimesulide (which was led by the well-known Aulin brand) switched to other OTC systemic analgesics, thus boosting sales of these products. According to industry sources, the switch of nimesulide mainly benefited products containing ketoprofen, ibuprofen, acetaminophen and naproxen.

SWITCHES

COMPETITIVE LANDSCAPE

  • Aziende Chimiche Riunite Angelini Francesco ACRAF SpA (Angelini) remained the leading company within analgesics in Italy in 2010, with 33% of sales value. Its leading position was due to the positive performance of systemic analgesics, such as acetaminophen, a category led by Aziende Chimiche Riunite Angelini Francesco through its Tachipirina brand. Moment, another popular Aziende Chimiche Riunite Angelini Francesco brand (a systemic analgesic), continued to benefit from the launch of Moment Act, a more powerful variant of the original, and at the end of 2010 from the launch of a new format of Moment – soft pills. On the topical side, Aziende Chimiche Riunite Angelini Francesco introduced Momenlocadol in patch format in 2009, and this helped it maintain its position in the category in 2010, with the product being used in case of acute pain with strains, sprains, etc.

PROSPECTS

  • During the forecast period, manufacturers will continue to focus on products based on ketoprofen and ibuprofen, and also acetaminophen and aspirin, so as to capitalise on the disappearance of nimesulide from the Italian OTC analgesics category. Moreover, the increase in the number of older consumers, who face arthritis pain and increased risk of heart attacks, will create a positive growth environment for analgesics.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Italy - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products recorded growth of 2% in current value in 2010, with sales reaching €10 million. The prevalence of sleep problems, particularly insomnia, has been found to be increasing, with Italians leading busier lifestyles and experiencing more stress, particularly with the recent economic downturn.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, the calming and sleeping products category continued to be led by Solvay Pharma SpA, although the company again lost share, with a decrease of one percentage point in that year, due to competition from new melatonin-based remedies.

PROSPECTS

  • Over the forecast period, retail sales of calming and sleeping products are predicted to post a CAGR of 1% in constant value terms. Increased levels of stress, potentially further exacerbated by economic worries, and the growing number of older Italians, are predicted to underpin the rising number of people with sleeping problems. Despite this, the calming and sleeping products category will not be particularly dynamic, as Italians will lean more towards changing their lifestyles and attitudes towards life rather than trying to manage stress. Anxiety pathologies are also expected to become more serious, thus needing Rx medicines. The calming and sleeping products category will remain driven mainly by natural and herbal-based remedies for temporary stress

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Italy - Category Analysis

HEADLINES

TRENDS

  • The influenza season in 2009/2010 was substantially stronger than in the preceding years, seeing a similar peak to that observed across 2004/2005. Nevertheless, consumers continued to express concerns regarding the adverse side effects of allopathic products. As a result, Italians are increasingly shifting towards natural remedies. In cases of cough, cold, flu and pharyngeal irritations, Italian consumers are accustomed to deciding themselves what product to use, usually well-known syrups and/or tablets, often after taking a chemist/pharmacist’s advice, rather than visiting a general practitioner for a prescribed drug.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Italian cough, cold and allergy remedies category is very fragmented, with the top 10 players accounting for just 52% of value sales in 2010. GlaxoSmithKline leads sales, with a total value share of 8%. This is despite the fact that none of its brands are in the top 10 in cough, cold and allergy remedies. The launch of the nasal decongestant plaster Breathe Right in 2008 helped consolidate GlaxoSmithKline’s lead.

PROSPECTS

  • Changing consumer attitudes to purchasing OTC products will be key to the performance of cough, cold and allergy remedies over the forecast period. Cough remedies will continue to be sold mainly through the chemist/pharmacy channel, since consumers will often require a chemist/pharmacist’s advice about their use (eg correct dosage, time of treatment, etc); however, decongestants and pharyngeal preparations are likely increasingly to be bought in the grocery channel. Consumers will find it more convenient and cheaper to purchase these products in supermarkets, due to their prices being 10-20% lower.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Italy - Category Analysis

HEADLINES

TRENDS

  • 2010 saw an increased trend of maintaining a healthy digestive system among consumers, and consequently preventative products became more popular, as consumers sought to avoid the use of symptom-relief products. In particular, consumers are increasingly choosing herbal formulations, which are perceived as less prone to side effects than synthetic digestive remedies. At the same time, Italians are showing an increasing preference for preventive measures, such as increased intake of water and fibre in their diets, together with less sedentary lifestyles, as well as greater interest in fibre supplements and probiotics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Mcneil led the category in 2010, accounting for 11% of value sales. The company entered the Italian OTC digestive remedies category in 2008, following the acquisition of the Imodium brand from Centro Medicamenta OTC Srl. The company’s leading position is due to the popularity of its brand Imodium, which is the leader in diarrhoeal remedies, and one of the few products available in this category.

PROSPECTS

  • Over the forecast period, retail sales of digestive remedies are projected to decline by an annual average of 1% in constant value terms, to €361 million at constant 2010 prices. The increasing proportion of elderly Italians, who usually suffer more from digestive problems, will contribute to future demand. However, improving daily diets, such as the increasing intake of fibre-rich food, is expected to impact demand for some remedies negatively. Increased awareness of healthy eating is likely to continue to encourage consumers to stay healthy, and the increased introduction of digestive care and maintenance products will help minimise the need for regular digestive relief products in the coming years.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Ear care sales remained fairly stable in 2010, recording growth of just 1% in current value, with sales reaching €21 million. There were no significant new product developments during the review period, which is reflective of manufacturers regarding this as a rather niche area in consumer health. Ear care products are mainly sedative and not curative, and can therefore easily be substituted by natural solutions. In general, consumers are either increasingly shifting towards natural solutions to cure minor illnesses, or are opting for Rx medicines for anything more serious.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Italian ear care category remained dominated by two main players in 2010: Laboratoire Vifor France SA and Zambon Italia SpA. Laboratoire Vifor France led with a current value share of 34%, thanks to the success of its Otalgan brand. Otalgan benefits from a long presence on the market and from being a well-known product, despite a lack of advertising investment. Zambon Italia SpA’s brand is Anauran, which continued to see its share decline in 2010, to 29% of value.

PROSPECTS

  • Over the forecast period, retail sales of ear care are expected to grow only slightly, with a CAGR of rather less than 1% in constant value terms. No significant new product development is expected in ear care, with the exception of natural remedies. Consumers will continue to shift towards either natural products or Rx medicines, which are perceived as safer or more effective than non-prescription medicines.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Eye care recorded a decrease of 1% in current value in 2010, with sales falling to €105 million. Convenience is becoming a key consideration in the choice of products, with consumers preferring single dose products over multi-dose formats. Single-dose products are easy to carry, more hygienic and do not require the consumer to remember the period of usage which the product must be limited to, unlike larger formats.

SWITCHES

COMPETITIVE LANDSCAPE

  • The eye care competitive landscape is led by a few key operators within the OTC market, but is also characterised by the presence of a large number of manufacturers mainly producing artificial tears.

PROSPECTS

  • OTC eye care products face strong competition from Rx products in the form of eye drops and creams. In addition for less serious pathologies, where self-medication is preferred, the use of dietary supplements at systemic level is increasing, as research is producing ever more specific supplements that provide certain active ingredients that are better absorbed systemically than topically. As a result, sales of eye care are predicted to decline further over the forecast period.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares by Value 2006-2010
  • Table 57 Eye Care Brand Shares by Value 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Italy - Category Analysis

HEADLINES

TRENDS

  • During the review period, clinical studies were conducted to test the efficacy of herbal products in the treatment of certain pathologies, such as inflammatory diseases (arthritis and back pain, for example), hypertension, and coughs and colds. In the last couple of years, much attention has also been paid to the body system as a whole. This has resulted in better information and wider knowledge about herbal products and their benefits. In 2010, demand for herbal/traditional remedies continued to be supported by consumers’ increased knowledge about the effectiveness of such remedies. Moreover, the category benefited from consumers’ concern over the negative side effects associated with some prescription and non-prescription medications. The negative reporting of these products has led consumers to seek out alternatives in herbal/traditional products, which are perceived as safer than prescription and non-prescription medications.

COMPETITIVE LANDSCAPE

  • The herbal/traditional remedies market is very fragmented, with the leading six players together accounting for 32% of total value sales. The leading player in 2010 was Aboca SpA, with a 10% value share, mainly driven by the dietary supplement Bio Valoe Detox, containing pure aloe juice from Venezuela, which is rich in substances that boost the immune system and has significant nutritive value. Aboca is very innovative in the natural fibre category, with Digerbe, and also with products for cholesterol and cardiovascular problems, such as ColesErbe. Aboca has also introduced new products within combination dietary supplements, for example with supplements specific for the memory, for the menopause and for the menstrual cycle. In dietary supplements, Aboca offers Immunomix for children and adults, which is one of the most successful products for boosting the immune system as a prevention against seasonal flu. Another successful line is Natura Mix, distributed especially in juice format to increase energy and give balance to the body system through vitamins, ginseng and other specific ingredients. The company is also present in the weight management category with the line Fitomagra, offering a wide range of purifying products and with ingredients that control the sense of hunger.

PROSPECTS

  • One of the key factors driving further development of herbal/traditional products will be the continuing appearance of clinical studies indicating the efficacy of these products. Research is likely to lean towards “dispositivi medico”, to treat symptoms through a mechanical effect rather than introducing active principles into the system (as allopathic medicines do), with the aim of eliminating side effects. Another factor boosting growth will be decreasing competition from homoeopathic products, which continue to be negatively impacted by unfavourable opinions from medical experts.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care sales benefited in 2010 from the increasing attention paid by consumers to their health and skin care. Healthy skin is considered an indicator of wellbeing and in particular general self-hygiene, favouring sales of medicated shampoo and antiparasitics for example. In addition, it is considered an important factor in self-confidence for Italians, thus favouring in this case sales of products such as hair loss treatments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer remained the leader in medicated skin care in 2010, accounting for 8% of total value sales. The company was able to maintain its leading position largely through its main umbrella brand, Canesten, where a selling point is that is can be used with children, with the sub-brands Gynocanesten and the nail antifungal Unidie. A significant contribution was also made by its secondary brands, such as Proctosedyl, in haemorrhoid treatments, and Bepanthol, which performed particularly well in 2010.

PROSPECTS

  • The medicated skin care category is expected to grow over the forecast period, although at a modest 1% constant value CAGR. However, this compares favourably with the review period performance, when sales were static in constant value terms. Neither consumers nor retailers see the medicated skin care category as a unified category. As a result, the overall category growth rate will be the result of the performances of a series of unrelated product types. In line with the trend of the review period, sales will benefit from Italian consumers’ growing interest in healthy skin, as part of overall good health. Proper skin care treatment is also widely regarded as essential in preventing premature skin ageing, which is an increasing concern among consumers in Italy.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 69 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 70 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 71 Acne Treatments Brand Shares by Value 2007-2010
  • Table 72 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 74 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Italy - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids performed strongly up until 2005, but have since seen a sharp decline, as consumers have lost interest in NRT smoking cessation aids. According to industry sources, there is a general weakening of anti-smoking sentiment amongst Italians. The problem is that the effect of the smoking ban, which was introduced in 2005, has decreased year-on-year, and many Italians have shown less determination to give up smoking. The majority of people who still smoke are well aware of the health impact of the habit, but nonetheless choose to continue. The declining trend of the NRT smoking cessation aids category is leading to a lack of interest among manufacturers, with little investment either in terms of advertising campaigns or new product development.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, only three manufacturers were present in NRT smoking cessation aids: Carlo Erba (Pfizer Group), with Nicorette; Novartis, with Nicotinell; and GlaxoSmithKline, with NiQuitin CQ. Carlo Erba OTC continued to dominate category sales in 2010, as in 2009, accounting for almost 75% of total value sales, through its Nicorette brand, which is the only NRT gum available on the Italian market. GlaxoSmithKline, which entered the market with NiQuitin CQ in 2005, was able to maintain its second position, despite a decrease in share, which was due mostly to the relatively poor performances of the categories in which it is present – patches and lozenges – and a drop in advertising investment, while Novartis Consumer Health ranked third, with its share decreasing on the previous year due to the company’s declining interest in these products.

PROSPECTS

  • All NRT smoking cessation aids categories are predicted to experience declines in sales over the forecast period, although in most cases at a slower rate than was seen in the review period. Gum is expected to see the smallest decline, as the most popular smoking cessation aids will be those with less nicotine and fewer side effects, and which can be used when a compulsive desire to smoke is felt. Moreover, consumers are likely to favour products that help them to control their weight while giving up smoking, as weight gain represents a problem for people who want to stop the habit.

CATEGORY INDICATORS

  • Table 75 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 76 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 77 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 78 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 79 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 80 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 82 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Italy - Category Analysis

HEADLINES

TRENDS

  • With longer working hours and rising obesity rates, Italians are increasingly expressing a willingness to increase their level of physical activity. Anecdotal evidence, as well as fitness industry sources, indicate that a rising number of people have a fitness club membership. This trend is further supported by vanity and health concerns among younger Italians, especially young single professionals, who pay considerable attention to their physical appearance and body shape, and for whom gym sessions are the most suitable sports activity in accord with their busy lifestyles, giving the opportunity of going at almost any time of day.

COMPETITIVE LANDSCAPE

  • Many of the most important brands in sports nutrition are from US or German multinationals, selling in Italy through local distributors. However, thanks to heavy investment in both research and advertising new products, the leading player in sports nutrition in 2010 was the domestic company Enervit SpA, followed by Proaction Srl, Ultimate Italia Srl, Multipower and Nutrilife Srl. An important trend is the increasing number of small distributors, which are increasing the level of competition for the leaders. These new companies are very small and, in an attempt to gain share in this category, have launched new products at very competitive prices. Many do not remain in the market for long, but in the meantime they create strong price competition, mostly damaging the larger brands.

PROSPECTS

  • Demand for sports nutrition is expected to increase over the forecast period, as the desire to remain healthy and active, along with maintaining good nutrition, remain growing trends in Italy. With an increasing obesity rate and more sedentary lifestyles, sports nutrition companies are expected to benefit from assisting consumers with their overall quest for fitness. Unlike weight loss supplements, which usually control the metabolism or calorie/fat absorption, sports nutrition can make a consumer’s workout more productive and rewarding in the long term.

CATEGORY DATA

  • Summary 36 Sports Nutrition: Category Rankings 2010
  • Table 83 Sales of Sports Nutrition: Value 2005-2010
  • Table 84 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 85 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 86 Sports Nutrition Company Shares 2006-2010
  • Table 87 Sports Nutrition Brand Shares 2007-2010
  • Table 88 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 89 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Italy - Category Analysis

HEADLINES

TRENDS

  • Despite increasing consumer concern over health-related problems and wellbeing, sales of vitamins saw only moderate growth in 2010. Vitamins remain attractive to many Italian consumers; however, the poor economic climate, with reduced household income levels, led many Italians to cut back on unnecessary items when possible, including vitamins. However, sales of dietary supplements continued to increase strongly, because supplements have more specific effect than vitamins in providing the body with substances that are lacking. In addition, supplements have replaced products that in previous years were topical. For example, supplements for eye health, hair loss and the treatment of acne are now available.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Whitehall Italia SpA, Sanofi-Aventis SpA and Bayer SpA continued to be the three leading companies in the vitamins and dietary supplements category in 2010. Whitehall reinforced its leading position in 2010 due to the competitive strength of its two main brands, Polase and Centrum. Polase registered an outstanding performance due to the company reducing prices, following Polase being reclassified as “Notificato” rather than OTC. Centrum is available in six different varieties, segmented by age and specific conditions, such as cardiovascular problems or for pregnant women. Sanofi-Aventis ranked in second position, and benefited from the positive performance of its Enterogermina brand, the leading brand in the very dynamic probiotic supplements category. The main brand in third-ranking Bayer’s portfolio is Supradyn, which is still the leader in multivitamins, but which registered a decrease in sales in 2010 due to the strong performances of Multicentrum and other, smaller brands.

PROSPECTS

  • Increased concern about health and well-being will lead to rising consumption of vitamins and dietary supplements across every age range, including babies and children, over the forecast period. The category will be impacted by the ageing of the Italian population, with many products being targeted specifically to meet the requirements of ageing consumers. Manufacturers will in the same way increasingly target specific consumer groups within the middle-aged population segment. For example, glucosamine saw good growth at the end of the review period due to its positioning for joints – an area of particular importance to the older population – and manufacturers are now beginning to target the supplement at people undertaking sporting activities, regardless of their age.

CATEGORY DATA

  • Summary 37 Dietary Supplements Brand Ranking by Positioning
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 91 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 92 Dietary Supplements by Positioning 2005-2010
  • Table 93 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 94 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 95 Vitamins Brand Shares by Value 2007-2010
  • Table 96 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 98 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Italy - Category Analysis

HEADLINES

TRENDS

  • Sales of slimming products saw a positive performance in 2010, driven by consumers’ desire to lose weight in order to reach their goal of having an attractive, slim body, and also because the correct weight is increasingly associated with health and wellness. Moreover, consumers demand was supported by a wide offer of high quality products, as manufacturers are required to meet the standards imposed by the relevant European law (Direttiva Europea 2002/46) for product quality and safety.

COMPETITIVE LANDSCAPE

  • Herbalife Italia SpA led sales of weight management products in 2010, due to its leading position in meal replacement products, with a 42% share of value, and its dominant position in weight loss supplements, with 56% of value. Herbalife heavily supports these products, as they are among its leading product lines. Its success is partly based on the fact that the company emphasises its worldwide, long-standing experience in high quality slimming products. Formula1 is the core product, with proven case studies showing that, once taken and following Herbalife instructions, it can be effective in achieving and maintaining the desired weight.

PROSPECTS

  • The forecast period is predicted to see a slight slowdown growth compared to the average growth rate observed in the review period, with a 2% CAGR. The market for weight management products has become more tightly regulated, in terms of both Italian and European laws, which greatly limits the launch of new products. New products will be subject to rigid checks with regards to slimming claims, in order to protect consumers and provide them with adequate information about the products’ actual benefits. Moreover, this category will continue to shift towards the use of more natural ingredients. Mixes of herbal extracts widely known as fat reducers, eg pineapple stem, or natural detoxifying diuretic products, eg birch, dandelion or acai, will increasingly be used in the formulas of slimming products, and consequently consumers will be reassured about the non-toxicity of new products.

CATEGORY DATA

  • Table 99 Sales of Weight Management: Value 2005-2010
  • Table 100 Sales of Weight Management: % Value Growth 2005-2010
  • Table 101 Weight Management Company Shares 2006-2010
  • Table 102 Weight Management Brand Shares 2007-2010
  • Table 103 Forecast Sales of Weight Management: Value 2010-2015
  • Table 104 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Wound care recorded growth of 4% in current value terms in 2010, with sales reaching €171 million. Price competition remained the key strategy in maintaining value share for the major players, both within the more dynamic sticking plasters category and in gauze and tape. Pharmacies decreased in shares, with sales being cannibalised by mass-market distribution channels.

COMPETITIVE LANDSCAPE

  • Private label holds a larger share than any individual manufacturer. However, in 2010 they record a decrease due to the intensive price competition applied by branded products. This is a category where brand loyalty is very low, since the quality of wound treatment products is considered more or less comparable across all types of standard products (eg plasters, gauzes and liquid disinfectants). As a result, consumers are inclined to buy the cheapest products in more commodified areas, such as plasters, particularly following the economic downturn. Brand is, however, considered important in the case of more innovative products, such as liquid and spray plasters.

PROSPECTS

  • Wound care sales are expected to grow at a CAGR of 1% between 2010 and 2015, to reach €177 million at constant 2010 prices. Price positioning is expected to continue to be important in wound care, with the major players looking to increase their shares. In order to compete effectively against private label, manufacturers are likely to continue to invest in the launch of new products, and this may well lead to a degree of polarisation in wound care. The forecast period is expected to be characterised by a higher increase in sales volume than in sales value, as a direct consequence of the increasing penetration of the private labels.

CATEGORY DATA

  • Table 105 Sales of Wound Care by Category: Value 2005-2010
  • Table 106 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 107 Wound Care Company Shares by Value 2006-2010
  • Table 108 Wound Care Brand Shares by Value 2007-2010
  • Table 109 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 110 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Fibre
            • Isoflavones
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Propolis
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report